Asserter profile
10x Genomics, Inc.
operating company1 patents now1 ever1 cases filed during tenure1 connections
Two-hop network
Edges marked ⚖️ overlap with at least one infringement suit filed during the receiving entity’s tenure with the patent. Bold-bordered = this entity. Red = NPE; orange = shell LLC; green = defensive aggregator; blue = operating company.
flowchart LR
N10x_genomics["10x Genomics, Inc."]
Nroyal_bank_of_canada["ROYAL BANK OF CANADA"]
N658276_n_b_658868_n_b_mosaid["658276 N.B. LTD., 658868 N.B. INC., MOS…"]
Nconversant_ip_n_b_868_conversant_intellectual_property_manag["CONVERSANT IP N.B. 868 INC., CONVERSANT…"]
N10x_genomics -->|"2023 · Security Agreement · 11021737"| Nroyal_bank_of_canada
Nroyal_bank_of_canada ==>|"⚖️ 2024 · Release · 11021737"| N10x_genomics
N658276_n_b_658868_n_b_mosaid -->|"2012 · Security Agreement · 7051306"| Nroyal_bank_of_canada
Nroyal_bank_of_canada -->|"2014 · Release · 7051306"| Nconversant_ip_n_b_868_conversant_intellectual_property_manag
N658276_n_b_658868_n_b_mosaid -->|"2012 · Security Agreement · 7685393"| Nroyal_bank_of_canada
Nroyal_bank_of_canada -->|"2014 · Release · 7685393"| Nconversant_ip_n_b_868_conversant_intellectual_property_manag
classDef focal fill:#fef3c7,stroke:#92400e,stroke-width:3px,color:#1c1917
classDef npe fill:#fee2e2,stroke:#be123c,stroke-width:2px,color:#1c1917
classDef shell fill:#fed7aa,stroke:#9a3412,stroke-width:2px,color:#1c1917
classDef defensive fill:#dcfce7,stroke:#15803d,stroke-width:2px,color:#1c1917
classDef operating fill:#e0f2fe,stroke:#075985,stroke-width:1px,color:#1c1917
class N10x_genomics focal
class Nroyal_bank_of_canada operating
class N658276_n_b_658868_n_b_mosaid npe
class Nconversant_ip_n_b_868_conversant_intellectual_property_manag npe
Patents currently held (1)
- US 110217372024-04-30 → present
- 10x Genomics, Inc. et al. v. Element Biosciences, Inc. filed 2026-05-08
Connected entities (1)
- ROYAL BANK OF CANADAoperating company1 patent · ⚖️ 1
Correspondent attorneys (1)
Attorneys / firms recorded with USPTO when this entity received a patent. Recurrence is the signal — many firms do both NPE and operating-company patent work, so a single appearance doesn’t mean much.
- Hylina E. Cannon· Dentons US1 appearance